Home Site Map
 

We are a biopharmaceutical company focused on discovering, developing and commercializing innovative products to address chemotherapy-induced nausea and vomiting, or CINV, pain management and other central nervous system disorders. We seek to apply new and proprietary formulations and delivery methods to existing pharmaceutical compounds in order to achieve enhanced efficacy, faster onset of action, reduced side effects, convenient delivery and increased patient compliance. Our drug development program is based on existing compounds with known safety, efficacy and commercialization histories. We believe this will increase the likelihood of success for our drug development and commercialization efforts.

Our goal is to leverage our expertise in the expanding fields of synthetic cannabinoid derivatives and specialized opioid therapies to build a portfolio of proprietary products that address the limitations of existing treatments.

More Information

 



As a growing specialty pharmaceutical company, INSYS Therapeutics seeks to build long-term relationships with a focus on strategic alliances and deals that strengthen our business.

Partners
Because of our entrepreneurial perspective and commitment to innovation, we constantly look for and evaluate strategic partnerships. Successful collaborations are based on complimentary strengths, goals and objectives.  Whether you are a research scientist working on an innovative concept, a biotech/pharma company in search of a development partner for your product or a business professional interested in exploring creative commercialization solutions for your company’s product, we welcome your inquiry. 

If you would like to learn more about INSYS Therapeutics or share your ideas, please contact us.





 
© 2008 Insys Therapeutics, Inc. All Rights Reserved.